{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:18:21Z","timestamp":1768817901001,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["CCT-A-1603"],"award-info":[{"award-number":["CCT-A-1603"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["CCT-B-1701"],"award-info":[{"award-number":["CCT-B-1701"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["CCT-C-1810"],"award-info":[{"award-number":["CCT-C-1810"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["CCT-C-2340"],"award-info":[{"award-number":["CCT-C-2340"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00415-019-09251-x","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T19:20:59Z","timestamp":1551986459000},"page":"1211-1221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials"],"prefix":"10.1007","volume":"266","author":[{"name":"JASMITT study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hashizume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Banno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoshi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Suga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amane","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hijikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-3181","authenticated-orcid":false,"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"9251_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A wsex-linked recessive trait. Neurology 18:671\u2013680","journal-title":"Neurology"},{"key":"9251_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue G, Hashizume Y, Mukai E et al (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112:209\u2013232","journal-title":"Brain"},{"key":"9251_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1001\/archneur.59.12.1921","volume":"59","author":"AD Sperfeld","year":"2002","unstructured":"Sperfeld AD, Karitzky J, Brummer D et al (2002) X-linked bulbospinal neuronopathy: Kennedy disease. Arch Neurol 59:1921\u20131926","journal-title":"Arch Neurol"},{"key":"9251_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1023\/A:1005344403603","volume":"20","author":"KH Fischbeck","year":"1997","unstructured":"Fischbeck KH (1997) Kennedy disease. J Inherit Metab Dis 20:152\u2013158","journal-title":"J Inherit Metab Dis"},{"key":"9251_CR5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/brain\/awl096","volume":"129","author":"N Atsuta","year":"2006","unstructured":"Atsuta N, Watanabe H, Ito M et al (2006) Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129:1446\u20131455","journal-title":"Brain"},{"issue":"24","key":"9251_CR6","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","volume":"19","author":"ES Chevalier-Larsen","year":"2004","unstructured":"Chevalier-Larsen ES, O\u2019Brien CJ, Wang H et al (2004) Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 19(24):4778\u20134786","journal-title":"J Neurosci"},{"key":"9251_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno M, Adachi H, Kume A et al (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35:843\u2013854","journal-title":"Neuron"},{"key":"9251_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno M, Adachi H, Doyu M et al (2003) Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9:768\u2013773","journal-title":"Nat Med"},{"key":"9251_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K et al (2009) Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 65:140\u2013150","journal-title":"Ann Neurol"},{"key":"9251_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, Banno H, Suzuki K et al (2010) Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:875\u2013884","journal-title":"Lancet Neurol"},{"key":"9251_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","volume":"10","author":"LE1 Fern\u00e1ndez-Rhodes","year":"2011","unstructured":"Fern\u00e1ndez-Rhodes LE1, Kokkinis AD, White MJ et al (2011) Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol 10:140\u2013147","journal-title":"Lancet Neurol"},{"key":"9251_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(14)70129-2","volume":"13","author":"H Mitsumoto","year":"2014","unstructured":"Mitsumoto H, Brooks BR, Silani V (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved. Lancet Neurol 13:1127\u20131138","journal-title":"Lancet Neurol"},{"key":"9251_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1044\/jslhr.4305.1264","volume":"43","author":"JA Logemann","year":"2000","unstructured":"Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA, Kahrilas PJ, Smith CH (2000) Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 43:1264\u20131274","journal-title":"J Speech Lang Hear Res"},{"key":"9251_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/archneur.1996.00550020045014","volume":"53","author":"The ALS CNTF treatment study (ACTS) phase I-II Study Group","year":"1996","unstructured":"The ALS CNTF treatment study (ACTS) phase I-II Study Group (1996) The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53:141\u2013147","journal-title":"Arch Neurol"},{"key":"9251_CR15","first-page":"346","volume":"53","author":"Y Ohashi","year":"2001","unstructured":"Ohashi Y, Tashiro K, Itoyama Y, Nakano I, Sobue G, Nakamura S et al (2001) Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS (ALSFRS-R) Japanese version. No To Shinkei 53:346\u2013355","journal-title":"No To Shinkei"},{"key":"9251_CR16","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","volume":"33","author":"UA Besinger","year":"1983","unstructured":"Besinger UA, Toyka KV, H\u00f6mberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A (1983) Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33:1316\u20131321","journal-title":"Neurology"},{"issue":"Suppl 3","key":"9251_CR17","doi-asserted-by":"publisher","first-page":"III16","DOI":"10.1007\/BF03161085","volume":"246","author":"C Jenkinson","year":"1999","unstructured":"Jenkinson C, Fitzpatrick R, Brennan C, Bromberg M, Swash M (1999) Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis\/motor neurone disease: the ALSAQ-40. J Neurol 246(Suppl 3):III16\u2013I21","journal-title":"J Neurol"},{"key":"9251_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.70.1.70","volume":"70","author":"C Jenkinson","year":"2001","unstructured":"Jenkinson C, Fitzpatrick R (2001) Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiatry 70:70\u201373","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9251_CR19","first-page":"483","volume":"56","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi T, Ohbu S, Saito M, Ito Y, Morikawa F, Tashiro K et al (2004) Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis assessment questionnaire 40 (ALSAQ-40). No To Shinkei 56:483\u2013494","journal-title":"No To Shinkei"},{"key":"9251_CR20","unstructured":"ICH guideline E2B (R2) (2001) Electronic transmission of individual case safety reports\u2014message specification (ICH ICSR DTD Version 2.1). Final Version 2.3, Document Revision 1 Feb 2001"},{"key":"9251_CR21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S1474-4422(16)30236-8","volume":"15","author":"PJ Kelly","year":"2016","unstructured":"Kelly PJ, Albers GW, Chatzikonstantinou A et al (2016) Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies. Lancet Neurol 15:1238\u20131247","journal-title":"Lancet Neurol"},{"key":"9251_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","volume":"10","author":"C Anderson","year":"2011","unstructured":"Anderson C, Teo K, Gao P et al (2011) Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 10:43\u201353","journal-title":"Lancet Neurol"},{"key":"9251_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1474-4422(07)70036-4","volume":"6","author":"K Vahedi","year":"2007","unstructured":"Vahedi K, Hofmeijer J, Juettler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215\u2013222","journal-title":"Lancet Neurol"},{"key":"9251_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.0000000000002354","volume":"86","author":"E Johansson","year":"2016","unstructured":"Johansson E, Cuadrado-Godia E, Hayden D et al (2016) Recurrent stroke in symptomatic carotid stenosis awaiting revascularization: a pooled analysis. Neurology 86:498\u2013504","journal-title":"Neurology"},{"key":"9251_CR25","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1212\/WNL.0000000000002497","volume":"86","author":"MR Sperling","year":"2016","unstructured":"Sperling MR, French J, Jacobson MP et al (2016) Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies. Neurology 86:1095\u20131102","journal-title":"Neurology"},{"issue":"4","key":"9251_CR26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/acn3.425","volume":"24","author":"H Banno","year":"2017","unstructured":"Banno H, Katsuno M, Suzuki K et al (2017) Swallowing markers in spinal and bulbar muscular atrophy. Ann Clin Transl Neurol 24(4):534\u2013543","journal-title":"Ann Clin Transl Neurol"},{"key":"9251_CR27","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2169\/internalmedicine.8799-16","volume":"56","author":"A Hashizume","year":"2017","unstructured":"Hashizume A, Banno H, Katsuno M et al (2017) Quantitative assessment of swallowing dysfunction in patients with spinal and bulbar muscular atrophy. Intern Med 56:3159\u20133165","journal-title":"Intern Med"},{"key":"9251_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.410440216","volume":"44","author":"M Li","year":"1998","unstructured":"Li M, Miwa S, Kobayashi Y et al (1998) Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 44:249\u2013254","journal-title":"Ann Neurol"},{"key":"9251_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.20735","volume":"59","author":"H Banno","year":"2006","unstructured":"Banno H, Adachi H, Katsuno M et al (2006) Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol 59:520\u2013526","journal-title":"Ann Neurol"},{"key":"9251_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","volume":"70","author":"RL Wasserstein","year":"2016","unstructured":"Wasserstein RL, Lazar NA (2016) The ASA\u2019s statement on p-values: context, process, and purpose. Am Stat 70:129\u2013133","journal-title":"Am Stat"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09251-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:13:36Z","timestamp":1583453616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["9251"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09251-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,7]]},"assertion":[{"value":"14 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MK and GS have received honoraria from Takeda Pharmaceuticals. All other authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}